Cargando…

Real-World Bleeding and Ischemic Events in Asian Patients on P2Y12-Inhibitors After Percutaneous Coronary Intervention: A National Claims Data Analysis

INTRODUCTION: The safety and effectiveness of potent P2Y12 inhibitors in East Asians have been questioned because of the higher bleeding tendency and lower thrombotic risk in this population. We comparatively evaluated the safety, effectiveness and treatment persistence of the dual antiplatelet ther...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Yonggu, Lim, Young-Hyo, Park, Yongwhi, Shin, Jinho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7854396/ https://www.ncbi.nlm.nih.gov/pubmed/33179207 http://dx.doi.org/10.1007/s12325-020-01526-4

Ejemplares similares

Influence of an abnormal ankle-brachial index on ischemic and bleeding events in patients undergoing percutaneous coronary intervention
por: Kim, Hangyul, et al.
Publicado: (2023)

Data on the impact of subclinical hypothyroidism on clinical outcomes following percutaneous coronary intervention
por: Lee, Yonggu, et al.
Publicado: (2017)

Prognosis of Claims‐ Versus Trial‐Based Ischemic and Bleeding Events Beyond 1 Year After Coronary Stenting
por: Butala, Neel M., et al.
Publicado: (2021)

Relationship Between Platelet Reactivity and Ischemic and Bleeding Events After Percutaneous Coronary Intervention in East Asian Patients: 1‐Year Results of the PENDULUM Registry
por: Nakamura, Masato, et al.
Publicado: (2020)

Ischemic and Bleeding Events Associated with Thrombocytopenia and Thrombocytosis after Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction
por: Roh, Ji Woong, et al.
Publicado: (2020)

Correction to: Relationship Between Platelet Reactivity and Ischemic and Bleeding Events After Percutaneous Coronary Intervention in East Asian Patients: 1‐Year Results of the PENDULUM Registry
Publicado: (2020)

Relationship of body mass index and waist circumference with clinical outcomes following percutaneous coronary intervention
por: Lee, Yonggu, et al.
Publicado: (2018)

A case report of type VI dual left anterior descending coronary artery anomaly presenting with non-ST-segment elevation myocardial infarction
por: Lee, Yonggu, et al.
Publicado: (2012)

P2Y12 Inhibitors in Acute Coronary Syndromes: A Real-World, Community-Based Comparison of Ischemic and Bleeding Outcomes
por: Sachdeva, Amit, et al.
Publicado: (2023)

Ischemic and Bleeding Risk After Percutaneous Coronary Intervention in Patients With Prior Ischemic and Hemorrhagic Stroke
por: Natsuaki, Masahiro, et al.
Publicado: (2019)

Prognostic Value of Machine‐Learning‐Based PRAISE Score for Ischemic and Bleeding Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
por: Shi, Boqun, et al.
Publicado: (2023)

Influence of concomitant percutaneous transluminal angioplasty with percutaneous coronary intervention on clinical outcomes of stable lower extremity artery diseases
por: Lee, Yonggu, et al.
Publicado: (2022)

Correction to: Prognostic Value of Machine‐Learning‐Based PRAISE Score for Ischemic and Bleeding Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
Publicado: (2023)

Double antithrombotic therapy for prevention of bleeding and ischemic events after percutaneous coronary intervention in patients with atrial fibrillation: A meta-analysis
por: Qiu, Mei, et al.
Publicado: (2021)

Prediction of Thrombotic and Bleeding Events After Percutaneous Coronary Intervention: CREDO‐Kyoto Thrombotic and Bleeding Risk Scores
por: Natsuaki, Masahiro, et al.
Publicado: (2018)

Lack of the association between height and cardiovascular prognosis in hypertensive men and women: analysis of national real-world database
por: Kim, Hack-Lyoung, et al.
Publicado: (2022)

Incorporation of Laboratory Test Biomarkers Into Dual Antiplatelet Therapy Score Improves Prediction of Ischemic and Bleeding Events in Post-percutaneous Coronary Intervention Patients
por: Sun, Chengming, et al.
Publicado: (2022)

Ischemic and Bleeding Outcomes According to the Academic Research Consortium High Bleeding Risk Criteria in All Comers Treated by Percutaneous Coronary Interventions
por: Doomun, Daphné, et al.
Publicado: (2021)

Implications of bleeding in acute coronary syndrome and percutaneous coronary intervention
por: Pham, Phuong-Anh, et al.
Publicado: (2011)

The Evolving Concept of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention: Focus on Unique Feature of East Asian and “Asian Paradox”
por: Kang, Jeehoon, et al.
Publicado: (2018)

Bivalirudin vs heparin in cardiac-cerebral ischemic and bleeding events among Chinese STEMI patients during percutaneous coronary intervention: a retrospective cohort study
por: Bai, Zhichao, et al.
Publicado: (2023)

Influence of glycoprotein IIb/IIIa inhibitors on bleeding events after successful resuscitation and percutaneous coronary intervention
por: Biever, Paul Marc, et al.
Publicado: (2019)

Residual Inflammatory Risk and its Association With Events in East Asian Patients After Coronary Intervention
por: Ahn, Jong-Hwa, et al.
Publicado: (2022)

Impact of heart failure severity and major bleeding events after percutaneous coronary intervention on subsequent major adverse cardiac events
por: Ikebe, So, et al.
Publicado: (2023)

Percutaneous coronary intervention in asians- are there differences in clinical outcome?
por: Koh, Angela S, et al.
Publicado: (2011)

Does dual vs. triple antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation lower the risk of bleeding at the cost of increased risk of ischemic events?()
por: Gupta, Kartik, et al.
Publicado: (2019)

Association between B-type natriuretic peptide and long-term mortality in patients with acute severe hypertension visiting the emergency department
por: Kim, Byung Sik, et al.
Publicado: (2022)

Bivalirudin in patients undergoing percutaneous coronary intervention and independent predictors of postoperative adverse events in these patients: A real world retrospective study
por: Hu, Yue-cheng, et al.
Publicado: (2021)

Impact of Incomplete Coronary Revascularization on Late Ischemic and Bleeding Events after Transcatheter Aortic Valve Replacement
por: Carmona, Adrien, et al.
Publicado: (2020)

Prediction of Ischemic Events after Percutaneous Coronary Intervention: Thrombelastography Profiles and Factor XIIIa Activity
por: Kreutz, Rolf P., et al.
Publicado: (2018)

Prognostic value of myocardial injury-related findings on resting electrocardiography for cardiovascular risk in the asymptomatic general population: the 12-year follow-up report from the Ansan-Ansung cohort
por: Shin, Jinho, et al.
Publicado: (2020)

Prognostic Impact of Baseline Hemoglobin Levels on Long‐Term Thrombotic and Bleeding Events After Percutaneous Coronary Interventions
por: Nagao, Kazuya, et al.
Publicado: (2019)

Total Thrombus‐formation Analysis System Predicts Periprocedural Bleeding Events in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
por: Oimatsu, Yu, et al.
Publicado: (2017)

Prediction of gastrointestinal bleeding events in patients with acute coronary syndrome undergoing percutaneous coronary intervention: An observational cohort study (STROBE compliant)
por: Zheng, Wen, et al.
Publicado: (2020)

Ischemia and Bleeding in Cancer Patients Undergoing Percutaneous Coronary Intervention
por: Ueki, Yasushi, et al.
Publicado: (2019)

Influence of changes in body fat on clinical outcomes in a general population: a 12-year follow-up report on the Ansan–Ansung cohort in the Korean Genome Environment Study
por: Kim, Byung Sik, et al.
Publicado: (2021)

Effectiveness of Percutaneous Coronary Intervention within 12 Hours to 28 Days of ST-Elevation Myocardial Infarction in a Real-World Chinese Population
por: Wu, Xingli, et al.
Publicado: (2013)

Comparative Risk of Hospitalized Bleeding of P2Y12 Inhibitors for Secondary Prophylaxis in Acute Coronary Syndrome After Percutaneous Coronary Intervention
por: Kumar, Arun, et al.
Publicado: (2022)

Real-world comparison of clopidogrel, prasugrel and ticagrelor in patients undergoing primary percutaneous coronary intervention
por: Krishnamurthy, Arvindra, et al.
Publicado: (2019)

Real-world treatment patterns and adverse events in metastatic renal cell carcinoma from a large US claims database
por: Pal, Sumanta, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_c7bp1ic91khug43bq7dnaecc19